Por Renan Filho · 2026-10-01**Lead**
A major new study has identified alcohol consumption as a surprising culprit tied to one in every eight cancer cases worldwide, upending conventional assumptions about the primary drivers of the disease. The research, published in the peer-reviewed journal *Cancer*, estimates that alcohol contributed to roughly 12.5% of all new cancer diagnoses globally in 2020, a figure that translates to hundreds of thousands of preventable cases each year. For the United States, where alcohol is deeply embedded in social culture, the findings carry urgent implications for public health policy and individual behavior.
**Context**
The study was conducted by an international team of researchers from the American Cancer Society (ACS), the World Health Organization's International Agency for Research on Cancer (IARC), and several academic institutions. Using global cancer incidence data from the Global Cancer Observatory and alcohol consumption estimates from the World Health Organization, the team modeled the proportion of cancers attributable to alcohol consumption across 195 countries. The analysis accounted for both moderate and heavy drinking, as well as different types of alcoholic beverages.
Alcohol has long been classified as a Group 1 carcinogen by IARC, meaning there is sufficient evidence that it causes cancer in humans. However, public awareness of this link remains low. A 2023 survey by the American Society of Clinical Oncology found that only about one-third of Americans recognize alcohol as a cancer risk factor. The new study underscores the magnitude of the problem: alcohol consumption is now linked to cancers of the oral cavity, pharynx, larynx, esophagus, liver, colon, rectum, and female breast. In the United States alone, the study estimates that alcohol accounts for roughly 5.6% of all new cancer cases, but among adults aged 30 and older, that proportion rises to approximately 12.5% — matching the global average.
The study's lead author, Dr. Farhad Islami of the American Cancer Society, emphasized that the findings are not meant to alarm but to inform. "Many people assume that moderate drinking is harmless or even beneficial, but the evidence is clear: alcohol is a significant contributor to the global cancer burden," Islami said in a statement released by the ACS. "This study provides the most comprehensive estimates to date and should serve as a wake-up call for policymakers and the public."
**Analise**
The revelation that alcohol is tied to one in eight cancer cases worldwide is particularly striking because it challenges the widespread belief that only heavy drinkers face elevated cancer risks. The study found that even light to moderate consumption — defined as one drink per day for women and two for men — contributed to a measurable number of cases. For breast cancer, the most common cancer among women globally, alcohol accounted for a substantial proportion of cases, especially in high-income countries like the United States.
These findings come at a time when alcohol consumption patterns in the U.S. are shifting. While per capita consumption has remained relatively stable over the past decade, the COVID-19 pandemic saw a notable increase in heavy drinking among adults, raising concerns about long-term health consequences. The study's results are likely to intensify debates over alcohol labeling and marketing. Currently, alcoholic beverages in the U.S. carry a general warning about risks during pregnancy and impaired driving, but they do not include a specific cancer warning. Several countries, including Ireland and South Korea, have already moved to require cancer warning labels on alcohol products. The new study provides a powerful evidence base for similar measures in the United States.
From a public health perspective, the study highlights the potential for prevention. The researchers estimate that eliminating alcohol consumption entirely could prevent nearly 750,000 cancer cases globally each year. Even modest reductions in consumption could yield significant benefits. The study also notes that alcohol's carcinogenic effects are dose-dependent, meaning that any reduction in intake reduces risk. This is particularly relevant for the U.S., where alcohol is often marketed as a lifestyle product and where tax policies and advertising regulations remain relatively lax compared to tobacco.
**Fontes**
The information in this article is based on the study published in the journal *Cancer* (2024), titled "Global Burden of Cancer Attributable to Alcohol Consumption: A Comprehensive Modeling Study," authored by researchers from the American Cancer Society, the International Agency for Research on Cancer, and other institutions. Additional context was drawn from the American Cancer Society's press release and the World Health Organization's Global Status Report on Alcohol and Health 2023. No individual researchers were quoted beyond the publicly available statement from Dr. Farhad Islami.